X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Metal & realty out of favour 
(Tue, 15 Apr 01:30 pm) 
 
Indian share markets continued to witness selling pressure in the post-noon trading session. Barring IT, all the sectoral indices are trading in the red with metal, realty and banking stocks being the biggest losers.

BSE-Sensex is down 185 points and NSE-Nifty is trading 63 points down. BSE Mid Cap is trading 0.4% down and BSE Small Cap index is trading down by 0.3%. The rupee is trading at 60.3 to the US dollar.

Steel stocks are trading mixed with Maharashtra Seamless and Adhunik Metaliks being the major gainers whereas Jindal Steel and SAIL are among the biggest losers. As per a leading financial daily, India turned into a net steel exporter in FY14 after a gap of five years. According to the Joint Plant Committee, steel exports increased by 4% to 5.6 million tonnes (mt) whereas steel imports slumped by 31% to 5.4 mt in 2013-14. Going forward, steel exports are likely to be hit by the recent rupee appreciation as well as the expected recovery in the infrastructure projects in the country post elections that is likely to boost domestic steel demand. Domestic steel consumption in FY14 clocked a growth of a mere 0.6%, the slowest in last four years, to reach 73.9 mt. However JSW Steel has said that despite improvement in domestic demand, steel companies will continue to focus on exports backed by higher production and no currency fluctuations.

Majority of the domestic pharma stocks are trading in the green with Panacea Biotech and Biocon being among major gainers. However, Elder Pharma and Divi's Laboratories are a few stocks trading in the red. As per a leading financial daily, Lupin has voluntarily recalled 9,210 bottles of antibiotic drug Suprax used in the treatment of bacterial infections. As per US Food and Drug Administration (USFDA), the recall has been initiated under Class III under which the drugs are not likely to cause adverse health consequences. Last year, Lupin had recalled 64,368 bottles of Suprax in the US market due to discolouration. According to the company, the present recall will not have any business consequence. Lupin stock is presently trading down marginally.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Metal & realty out of favour". Click here!

  
 

S&P BSE HEALTHCARE


Jun 27, 2017 02:12 PM

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS